Status:
TERMINATED
Viral & Host Factors Associated With Hepatitis B Virus-related Hepatocellular Carcinoma
Lead Sponsor:
Stanford University
Conditions:
Liver Cancer
Hepatitis B
Eligibility:
MALE
18+ years
Brief Summary
Adult liver cancer is the third leading cause of cancer deaths worldwide. The major risk factor for liver cancer is hepatitis B virus (HBV) infection. The purpose of the study is to sequence the HBV g...
Eligibility Criteria
Inclusion
- Patients diagnosed with liver cancer based on biopsy or serum AFP level, associated with characteristic hypervascular liver tumors on triphasic spiral CT scan or MRI.
- 2\. Patients with non-cancer liver conditions such as cirrhosis, adenoma, cholangioma, or nodular hyperplasia.
- 3\. Patients with hepatitis B or hepatitis C viral infections not associated with liver cancer.
Exclusion
- No other patients except those listed above will be recruited. Additionally, patients will be excluded if, upon looking through their medical records, information required for data analysis are missing.
Key Trial Info
Start Date :
March 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2013
Estimated Enrollment :
135 Patients enrolled
Trial Details
Trial ID
NCT00767936
Start Date
March 1 2008
End Date
September 1 2013
Last Update
June 29 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Stanford University School of Medicine
Stanford, California, United States, 94305